Effects of haloperidol and physostigmine on self-administration of local anesthetics

https://doi.org/10.1016/0091-3057(82)90138-1Get rights and content

Abstract

Four rhesus monkeys were maintained under a FR 10 schedule of cocaine (0.1 mg/kg) or procaine (0.4 or 1.6 mg/kg) delivery. Haloperidol (0.01–0.08 mg/kg), physostigmine (0.0125–0.1 mg/kg) or saline treatments were administered prior to sessions in which responding was maintained by each of these drugs. Haloperidol produced dose-related increases in the self-administration of cocaine and dose-related decreases in the self-administration of both doses of procaine. Physostigmine produced dose-related decreases in the self-administration of both cocaine and procaine. These results suggest that the reinforcing properties of cocaine are specifically modified by drugs which interact with catecholamines. On the other hand, it seems unlikely that the reinforcing properties of procaine are mediated by the same mechanism. While the results of this experiment indicate that cholinergic mechanisms may not play a major role in mediating the reinforcing properties of either drug, additional studies with other cholinergic agonists and particulary antagonists as well as additional procedures are needed.

References (19)

There are more references available in the full text version of this article.

Cited by (48)

  • Rivastigmine does not alter cocaine-induced subjective effects or self-administration

    2019, Pharmacology Biochemistry and Behavior
    Citation Excerpt :

    This hyper-cholinergic state of reduced motivation has been correlated with reduced drug-seeking behavior and reduced rewarding effects of substances. For example, rhesus monkeys given the acetylcholinesterase-inhibitor (AChEi) physostigmine exhibit decreased cocaine self-administration (de la Garza and Johanson, 1982). In rat lines, Grasing et al. (2011) observed decreased self-administration of cocaine during active treatment with AChEis rivastigmine and donepezil, with persistent decreases noted after discontinuation of donepezil but not rivastigmine.

  • A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders

    2016, Behavioural Brain Research
    Citation Excerpt :

    An early study found that pretreatment with single doses of the cholinesterase inhibitor physostigmine (0.1–0.5 mg/kg) decreased cocaine self-administration in rhesus monkeys under FR-1 and caused vomiting and diarrhea [129], consistent with its administration at relatively high dose causing reward inhibition. When either cocaine or procaine were self-administered by rhesus monkeys under FR-10, 0.02–0.05 mg/kg doses of physostigmine increased responding in 3 of 10 sessions, with declines uniformly observed following greater physostigmine doses [175]. This inverted “U” dose-response relationship is again consistent with reward enhancement and inhibition, respectively.

  • Cholinergic modulation of food and drug satiety and withdrawal

    2012, Physiology and Behavior
    Citation Excerpt :

    Different lines of research suggest a fundamental role for accumbens cholinergic interneurons in drug reward. Systemic injection of acetylcholinesterase inhibitors, which serve as indirect ACh agonists by inhibiting ACh enzymatic degradation, can decrease cocaine self-administration in monkeys [36], block heroin seeking [37], and prevent cocaine and heroin conditioned place preference in rats [38], as well as preference for cocaine in mice [39]. Other studies have assessed the specific role of cholinergic interneurons in the NAc in the development of cocaine conditioning.

View all citing articles on Scopus
View full text